Ali Satvat - Director, Eidos Therapeutics, Inc

As of May 29, 2020


Ali Satvat Net Worth

  • Net worth is estimated to be at least $614.36M
  • Owns at least 24,575,501 units of Eidos Therapeutics, Inc stock
  • Sold an estimated value of $3.6M in the last 2 years at Eidos Therapeutics, Inc

Ali Satvat Trading

  • Largest purchase of shares was 1,103,848 units , worth over $28.62M on May 29, 2019
  • Largest sale of shares was 211,762 units , worth over $3.6M on June 22, 2018
  • In total has made about 6 transactions over 2 years
  • Usually trades in June, July and May, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Ali Satvat Mailing Address

  • Mailing address is C/o Kohlberg Kravis Roberts & Co. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 CA

Eidos Therapeutics, Inc Insider Trading

  • The most recent transaction was 14,428,836 units bought on January 26, 2021 by Bridgebio Pharma Inc worth over $0
  • In the last 3 years, insiders at Eidos Therapeutics, Inc sold an estimated value of $34.74M and bought an estimated value of $352.62M
  • The most active traders are Jonathan Fox, See Remarks,  Cameron Turtle, Chief Business Officer,  and Christine Siu, CFO and Secretary
  • Insider trading is most common in June, with the busiest year in 2019

Eidos Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1